Stochastic mechanisms are sometimes utilized to diversify cell fates, especially in nervous systems. In the Drosophila retina, stochastic expression of the PAS-bHLH transcription factor Spineless (Ss) controls photoreceptor subtype choice. In one randomly distributed subset of R7 photoreceptors, Ss activates Rhodopsin4 (Rh4) and represses Rhodopsin3 (Rh3); counterparts lacking Ss express Rh3 and repress Rh4. In the dorsal third region of the retina, the Iroquois Complex transcription factors induce Rh3 in Rh4-expressing R7s. Here, we show that Ss levels are controlled in a binary on/off manner throughout the retina yet are attenuated in the dorsal third region to allow Rh3 coexpression with Rh4. Whereas the sensitivity of rh3 repression to differences in Ss levels generates stochastic and regionalized patterns, the robustness of rh4 activation ensures its stochastic expression throughout the retina. Our findings show how stochastic and regional inputs are integrated to control photoreceptor subtype specification in the Drosophila retina.
INTRODUCTION
The Drosophila eye provides an excellent paradigm to study how stochastic and regionalized regulatory inputs intersect to affect cell fate specification. Underlying its uniform morphology, the fly eye contains two randomly distributed subtypes of ommatidia (unit eyes) defined by the mutually exclusive expression of specific Rhodopsin (Rh) proteins in the inner photoreceptors (R7 and R8). In the pale (p) subtype, pR7s express Rhodopsin3 (Rh3) and pR8s express Rhodopsin5 (Rh5), whereas in the yellow (y) subtype, yR7s express Rhodopsin4 (Rh4) and yR8s express Rhodopsin6 (Rh6). Although the p and y subtypes are randomly distributed, they consistently occur in a p:y ratio of $35:65 (Bell et al., 2007; Johnston and Desplan, 2010) (Figures 1A, 1B, 1D, and 1F) . Throughout the majority of the retina, the mutually exclusive expression of Rhs defines the p and y ommatidial subtypes. However, in the dorsal third region of the retina, Rh3 is coexpressed with Rh4 in yR7s. Thus, the dorsal third region consists of p ommatidia containing pR7s that express Rh3 only and ''dorsal third y'' ommatidia containing yR7s that express both Rh4 and Rh3 ( Figures 1C-1E ) (Mazzoni et al., 2008) .
Stochastic ommatidial subtype specification is controlled by the PAS-bHLH transcription factor Spineless (Ss) (Wernet et al., 2006) . Ss is expressed in a random subset of R7s where it determines y subtype fate. In yR7s, Ss has three main functions: (1) activate Rh4, (2) repress Rh3, and (3) repress a signal from R7 to R8, leading to the default yR8 fate (Rh6 expression) ( Figure 1B ). In the absence of Ss, pR7 fate (Rh3 expression) and pR8 fate (Rh5 expression) are induced ( Figure 1A ).
yR7-specific expression of Rh4 appears to be simply activated by Ss. In contrast, pR7-specific expression of Rh3 is regulated by complex interlocked feedforward loops of transcription factors (Johnston et al., 2011) . The Defective Proventriculus (Dve) homeodomain protein, a repressor that directly binds the rh3 promoter, is a critical node in this motif (Figures 1A and 1B) . The Orthodenticle (Otd) homeodomain protein activates Dve expression in all PRs, whereas the Spalt zinc finger transcription factors (Salm and Salr, referred to collectively as ''Sal'') repress Dve in R7s (Figures 1A and 1B) . In pR7s, Sal and Otd together activate Rh3 in the absence of Dve ( Figure 1A ). In yR7s, Ss reactivates Dve that represses Rh3 despite the presence of Otd and Sal ( Figure 1B ) (Johnston et al., 2011; Sood et al., 2012) .
The regionalized coexpression of Rh3 in Rh4-expressing yR7s in the dorsal third of the retina is activated by the transcription factors of the Iroquois Complex (IroC) ( Figures 1C-1E ) (Mazzoni et al., 2008) . Whereas Ss provides a stochastic input, IroC supplies a regionalized input into the regulation of Rh expression.
Here, we show that, as in other biological contexts, Spineless acts with the ubiquitously expressed PAS-bHLH protein, Tango (Tgo) (Emmons et al., 1999) , to regulate Rh expression. We show that the proper stochastic and regional control of Rh expression requires five mechanistic features: (1) Ss levels are high in yR7s in the main part of the retina to ensure repression of Rh3 and activation of Rh4, (2) Ss levels are reduced in dorsal third yR7s to allow Rh3 expression, (3) IroC activates Rh3 in dorsal third yR7s, (4) low Ss levels (as found in dorsal third yR7s) are sufficient to activate Rh4 expression, and (5) the absence of Ss expression produces pR7 fate including expression of Rh3 and absence of Rh4. The sensitivity of rh3 to regional inputs is likely due to the presence of multiple IroC (activating) and Dve (repressing) binding sites in the rh3 promoter, whereas the robustness of Rh4 activation appears to be due to the presence of a single Ss (activating) binding site. Our data demonstrate how stochastic and regionalized regulatory inputs are integrated to determine ommatidial subtype specification throughout the retina.
RESULTS

Tgo Is Required for Stochastic Rh Expression
In most biological contexts, the Tgo PAS-bHLH transcription factor is required as a heterodimeric partner for Ss function. Ss is expressed in specific cell types where it binds ubiquitously-expressed Tgo in the cytoplasm. The Ss/Tgo heterodimer then localizes to the nucleus to regulate target genes (Emmons et al., 1999; Ward et al., 1998) . Although it has been suggested that Ss works independently of Tgo in some contexts, these analyses were conducted with available tgo alleles, which were all hypomorphs (Kim et al., 2006) .
Because we could not detect staining in the eye using the available Tgo antibody (data not shown), we generated a tgo transcriptional reporter (tgo prom >nuGFP) that drove GFP expression in all cells in the retina including all R7 cells, consistent with previous reports that Tgo is ubiquitously expressed ( Figure 2O ).
To clearly ascertain the role of Tgo in stochastic Rh regulation, we generated two tgo null mutant alleles, tgo del6 and tgo
del25
, using the hobo transposable element system (see Experimental Procedures). tgo del6 removes the bHLH, PAS, and PAC domains required for dimerization and DNA binding, whereas tgo del25 removes the entire tgo locus and part of the 3 0 UTR region of the neighboring cg11986 gene (Figures 2A and 2B Figure S1A available online). Retinas in which tgo was knocked down using RNAi as well as tgo null mutant clones displayed a similar phenotype ( Figures 2F, 2J , and S1B). tgo null mutants faithfully phenocopied ss null mutants for all features of Rh regulation including derepression of the signal to R8s causing a dramatic increase in the frequency of Rh5-expressing R8s ( Figures  2H and 2I) , loss of Dve expression in yR7s ( Figure 2L ), and no effect on general cell fate markers ( Figures S1C-S1G) .
Consistent with the requirement of Ss/Tgo dimerization for efficient localization to the nucleus, Ss was not detectable in nuclei in tgo null mutant clones ( Figure 2K ). Further, although we could detect nuclear Ss in all photoreceptors when provided ectopically by a strong heterologous promoter (lGMR>Gal4), this localization was dramatically weaker in tgo mutant tissue compared to neighboring wild-type tissue ( Figure 2N ).
Tgo is cell autonomously required for regulation of Rh expression by Ss because ectopically-expressed Ss induced expression of Rh4 in all PRs and repression of Rh3 in all R7s in wildtype clones, but failed to do so in tgo null mutant clones, leading to Rh3 expression and loss of Rh4 in all R7s ( Figure 2M ).
Ss is also required for the elaboration of dendrites in ''dendrite arborization'' (da) sensory neurons. Although the hypomorphic tgo 5 allele exhibited no dendritic arborization defects (Kim et al., 2006) , tgo null mutant clones displayed decreases in the number of dendritic termini similar to ss null mutants, suggesting that Tgo is required for all Ss functions (Figures S1H-S1L).
Stochastic Binary On/Off Regulation and Regional Modulation of Levels Determine Ss Expression Rh3 and Rh4 are expressed in mutually exclusive R7 subtypes in the main part of the retina. However, in the dorsal third region, IroC activates Rh3 coexpression in Rh4-expressing yR7s. We hypothesized that Ss could also play a role in this coexpression phenomenon and thus, we assessed the levels of Ss protein to determine regional differences across the retina. We defined four regions of the retina based on ommatidium position relative to the equator: dorsal third (DT), dorsal equatorial (DE), ventral equatorial (VE), and ventral third (VT). Ss was expressed in an on/off manner across the retina as indicated by the bimodal Rh3 and Rh4 Are Differentially Responsive to Ss/Tgo Activity Levels We hypothesized that the reduced levels of Ss in the DT lower repression and allow IroC-mediated activation of Rh3 in yR7s in this region. rh4>ss generates a positive feedback loop to increase levels of Ss specifically in yR7s. These increased levels of Ss caused repression of Rh3 in yR7s in the DT (Figures 4A and 4G) , showing that Ss must be maintained at low levels to allow for Rh3 expression. Therefore, Rh3 and Rh4 appear to be differentially responsive to modulation of Ss levels in regions of the retina. Whereas Rh3 repression is sensitive to the reduction of Ss levels in the DT, Rh4 activation is robust. We characterized these differences further by evaluating a series of ss and tgo mutant alleles that cause premature termination and truncation of activation domains, leading to reduction in activity levels (Figures 2B and 5A) . To determine the molecular lesions, we sequenced the ss 116.4 , tgo 6 and other ss alleles (Figures 2B, 5A, and Experimental Procedures).
Including the ectopic expression of Ss experiment, we observed six phenotypic classes:
(1) Increased levels in yR7s ( /def): Derepression of Rh3 occurred in nearly all R7s. Rh4 was still expressed in stochastically distributed yR7s, but the frequency was subtly reduced in the DT region (Figures 4E and 4G) . (6) ): Rh3 was expressed and Rh4 was lost in all R7s (Figures 4F and 4G) .
These data show that Rh3 and Rh4 respond differently to Ss/Tgo activity levels. Lowering Ss/Tgo activity allowed for derepression of Rh3 without affecting activation of Rh4 in yR7s. Rh3 was susceptible to an underlying dorsal/ventral gradient of regulation because the region in which Rh3 coexpresses with Rh4 in yR7s expanded ventrally as Ss/Tgo activity decreased. Whereas Rh3 was very sensitive to Ss/Tgo activity levels, Rh4 was robust, with only subtle changes in the frequency of Rh4 expression observed in the DT (where Ss levels are reduced) in the strongest loss-of-function alleles. Our data suggest that Ss/Tgo activity occurs at specific levels to induce repression of Rh3 in yR7s throughout the majority of the retina while allowing coexpression with Rh4 in yR7s of the DT region.
Rh Regulation Is Sensitive to the Activation Capacity of Ss
The ss/tgo allelic series suggested that the C-terminal activation domains are important for the regulation of Rh expression in R7s. For the tgo alleles, the degree of activation domain truncation correlated with the loss of activation capacity and phenotypic severity ( Figures 2B, 4C , 4D, 4F, and 4G) (Sonnenfeld et al., 2005) .
To further characterize the differential response of Rh3 and Rh4 to Ss/Tgo activity levels, we used gain-of-function assays with Ss proteins with deletions of functional domains. The Ss bHLH domain binds DNA sequences in target genes upon (E) In ss 116.5 mutants, Rh3 expression in yR7s expands to the entire retina. These retinas are composed of R7s that express Rh3 alone or coexpress Rh3 with Rh4.
The frequency of Rh4 expression is slightly reduced in the DT. (F) In tgo del6 mutants, Rh4 is lost and Rh3 is expressed in all R7s throughout the retina.
(G) Quantification of the series of ss and tgo alleles. Data are presented in order of decreasing Ss/Tgo activity (i.e., increasing phenotypic severity). The six main phenotypic classes are separated by dashed lines.
dimerization with Tgo. The PAS domains mediate Ss/Tgo dimerization whereas the PAC motif contributes to folding of the PAS domain. The C-terminal region functions as an activation domain ( Figure 5A ) (Crews, 1998; Crews and Fan, 1999; Ponting and Aravind, 1997; Zhulin et al., 1997 Figures 5B, 5E , S2J, and S2L-S2N), consistent with critical roles for the bHLH and N-terminal PAS domains. We confirmed that these nonfunctional transgenes were indeed expressed using Ss antibody staining ( Figures S2E-S2I) .
Truncation of the C-terminal region reduces the transcriptional activity of the Ss protein. However, these changes in Ss could also impair heterodimerization with Tgo, prevent nuclear localization, or destabilize the protein in a nonspecific way. We therefore tested the Ss modified proteins for their capacity to localize Tgo to the nucleus. Ectopic expression of Ss driven by the engrailed promoter (en>Gal4) caused Tgo nuclear localization in the ectodermal en stripes in the fly embryo (Figures 5B and 5F) (Emmons et al., 1999) . Another PAS-bHLH partner of Tgo, Trachealess, localizes Tgo to the nucleus in tracheal tubules and salivary primordia, serving as an internal control for Tgo antibody staining (Figures S2T-S2BB) (Ward et al., 1998) . Ss DC1 , Ss
DC2
, and Ss DC3 induced Tgo nuclear localization as well as Ss wild-type , suggesting that truncation of the C-terminal activation region does not impair heterodimerization, localization, or stability ( Figures 5B, 5F , S2T, and S2Z-S2BB). Ss DPAC was also sufficient to induce Tgo nuclear localization, consistent with the dispensability of the PAC domain in the retina ( Figures  5B, 5F , and S2Y). Interestingly, Ss DPAS -C was only able to induce lower levels of Tgo localization ( Figures 5B, 5G , and S2X), suggesting that the C-terminal PAS domain increases the efficiency for dimerization and nuclear localization but is not absolutely required. As expected, Ss
DbHLH
, Ss DPAS-N , and Ss
DPAS/PAC
were not able to induce Tgo nuclear localization (Figures 5B, 5H, and S2U-S2W). This structure/function analysis of Ss is consistent with the ss/ tgo allelic series. Ss and Tgo proteins with truncations of the C-terminal activation domains causing reduced activity levels were able to induce Rh4 expression, but not Rh3 repression.
Stochastic and Regional Expression of Rh3 Is Controlled by Repressing and Activating Inputs
Ss/Tgo does not regulate rh3 directly, but rather activates Dve to repress rh3 in yR7s ( Figures 1A and 1B) . However, Dve is expressed at levels that allow IroC to overcome repression and activate Rh3 in yR7s of the DT region (Johnston et al., 2011) . We wondered whether Dve expression levels were affected in hypomorphic mutant situations that displayed Rh3 derepression. In tgo 5 mutant clones, Dve expression was decreased but not lost ( Figures 6A and 6B) . Thus, the dramatic changes in Rh3 expression observed upon modulation of Ss/Tgo activity appear to be mediated by changes in Dve levels. rh3 regulation is controlled by repressing (Dve) and activating (Otd, Sal, IroC) inputs. We next tested whether the sensitivity of rh3 regulation extends to its promoter. The rh3 promoter contains three canonical binding sites (TAATCC) for the K 50 homeodomain transcription factors, Dve and Otd ( Figure 6C ) (Johnston et al., 2011; Tahayato et al., 2003) . In yR7s, these sites appear to mediate repression by Dve. A 194 bp rh3 promoter (rh3 prom >GFP) induced expression in only pR7s in the main part of the retina and in both pR7s and yR7s in the DT region, similar to the Rh3 protein ( Figure 6E ). Mutation (K 50 mut1) of the distal K 50 site (K 50 -1) caused derepression in yR7s of the DE region ( Figure 6F ) whereas mutation (K 50 mut2) of the proximal site (K 50 -2) led to derepression in yR7s of the DE and VE regions ( Figure 6G ). Mutation of both sites (K 50 mut12) caused derepression in yR7s throughout the retina ( Figure 6H ). We next tested the roles of the four putative IroC binding sites in the rh3 promoter ( Figure 6C ) (Bilioni et al., 2005) . Mutation of 3 of 4 sites (IroC mut134) or all four sites caused a complete loss of expression in DT yR7s ( Figure 6D and data not shown). Both sets of mutations caused some loss of expression in pR7s, suggesting that these sites may also play a limited role in basal activation of rh3. These data suggest that IroC directly binds the rh3 promoter to upregulate expression in the DT.
Thus, Dve and IroC binding sites are critical for the sensitivity of rh3 to this regulatory network, dictating regional activation or repression outcomes in yR7s. The dorsal/ventral effects of these promoter mutations closely mirror the ss/tgo allelic series (Figures 4A-4F and 6D-6H) .
In summary, removing IroC activity or IroC binding sites causes loss of Rh3 expression in DT yR7s whereas ectopic expression of IroC at high levels induces Rh3 in the main region ( Figure 6D ) (Mazzoni et al., 2008) . Removing Ss/Tgo or Dve activity, or Dve binding sites causes derepression in the main region whereas increasing levels of Ss/Tgo or Dve causes repression of Rh3 in DT yR7s ( Figures 4A-4G , 6A, 6B, and 6F-6H) (Johnston et al., 2011) . We conclude that Rh3 expression in DT yR7s is controlled by both activation by IroC and a release of repression by Dve (and indirectly Ss) on the rh3 promoter.
Rh4 Activation Is Robust to Modulation of Ss/Tgo Activity
The Ss/Tgo heterodimer is a transcriptional activator that could act directly on the rh4 promoter to induce expression. Ss/Tgo binds xenobiotic response elements (XREs; core sequence: CACGC) to activate target genes (Emmons et al., 1999) . A 455 bp rh4 promoter (rh4 prom >GFP) induced expression that recapitulates endogenous Rh4 expression in yR7s ( Figures 7A  and 7B ) (Fortini and Rubin, 1990) . We identified one core XRE site that is conserved in all 12 sequenced Drosophila species examined ( Figure 5D ). The XRE is part of a larger element previously defined as RUS4A (TTTGCGGGCACGCAA) that is required for rh4 reporter expression (Fortini and Rubin, 1990) . A single point mutation in the XRE (to CAAGC) led to nearly complete abrogation of reporter expression (<2% R7s expressed GFP) ( Figures 7B and 7C) . Thus, the XRE sequence is required for rh4 expression, strongly suggesting that Ss/Tgo directly binds the rh4 promoter to induce expression.
Because Ss levels were lower in the DT, we wondered if Rh4 transcription levels were also reduced. Rh4 protein appears to be lower in the DT, although this could be due to Rh4 competing with Rh3 protein for rhabdomeric space. We assessed rh4 transcription with the rh4 prom >GFP reporter gene, which showed no difference in levels between the DT (where Ss levels are low) and VT (where Ss levels are high) ( Figures 7E and 7F ), suggesting that reduction in Ss levels in the DT does not affect Rh4 expression. We also evaluated rh4 prom >GFP in mutant clones that have reduced Ss/Tgo activity. rh4 prom >GFP was expressed at similar levels in tgo 5 and neighboring wild-type clones ( Figures 7G and   7H ), suggesting that activation of rh4 is robust to perturbations of Ss/Tgo activity. Because Ss is expressed at lower levels in the DT, the responsiveness of the rh4 promoter ensures that Rh4 is still activated there. In contrast, rh3 expression is sensitive to levels of Ss/Tgo activity to induce expression in DT yR7s and repression in main region yR7s.
DISCUSSION
The complex expression pattern of Rhs in R7s requires the integration of stochastic and regional regulatory information. In the main part of the retina, high levels of Ss in yR7s ensure repression of Rh3 and activation of Rh4. In the DT, reduced Ss levels >GFP is expressed in yR7s throughout the retina (including DT, DE, VE, and VT).
Developmental Cell
Stochastic and Regional Inputs Control PR Subtypes prom >GFP with wild-type XRE recapitulates Rh4 protein expression.
(C) Expression is lost with a point mutation in the XRE.
(D) Sequence alignment of the rh4 promoter for 12 Drosophila species highlighting the known cis-regulatory elements. The XRE core sequence is perfectly conserved in all 12 species. Sequence alignment was from the UCSC Genome Browser (http://genome.ucsc.edu/) (Fujita et al., 2011; Kent, 2002; Kent et al., 2002) . (E) rh4 prom >GFP is expressed at similar levels in the DT.
(F) rh4 prom >GFP is expressed at similar levels in the VT.
(G) rh4 prom >GFP is expressed at similar levels in tgo 5 and wild-type yR7s. Panel 1, GFP, Rh4, and Rh3; panel 2, GFP alone; panel 3, Rh4 alone; panel 4, Rh3 alone.
The white circle indicates a tgo 5 mutant yR7 that expresses rh4 prom >GFP with both Rh3 and Rh4. The solid gray circle indicates a wild-type yR7 that expresses rh4 prom >GFP with Rh4 alone. The dotted gray circle indicates a pR7 that expresses Rh3 alone.
(H) Quantification of rh4 prom >GFP levels in tgo 5 and wild-type yR7s. tgo 5 mutant yR7s (magenta) express rh4 prom >GFP at similar levels to wild-type yR7s (red).
Error bars are ±1 SD around the mean.
Stochastic and Regional Inputs Control PR Subtypes allow IroC-mediated activation of Rh3, yet are sufficient to activate Rh4. IroC activates Rh3 in the DT where Ss levels are lower (Figure 8H) . In IroC mutants, even the low levels of Ss in the DT are sufficient to induce repression of Rh3 (indirectly through Dve) ( Figure 8G ). Reciprocally, high levels of IroC are sufficient to induce Rh3 in the main part of the retina despite the presence of normal levels of Ss ( Figure 8I ).
The regional regulation of rh3 also requires reduction of Ss (and Dve) levels in the DT. In wild-type animals, Ss levels are high in yR7s in the main region to induce repression of Rh3 and low in the DT to allow Rh3 expression ( Figure 8B ). Increasing the levels of Ss in the DT causes Rh3 repression in yR7s (Figure 8A) . As the activity of Ss/Tgo is lowered in mutant conditions, Rh3 expression expands ventrally in the DE ( Figure 8C ) and then throughout the retina (Figures 8D-8F ). This intermediate expansion into the DE may be explained by the dynamic nature of IroC expression. IroC is initially expressed in all cells of the dorsal half (DT and DE) of the retina and then becomes restricted to the DT (Mazzoni et al., 2008; Sato and Tomlinson, 2007; Tomlinson, 2003) . Perhaps, residual levels of IroC and/or chromatin changes induced at the rh3 promoter increase the activation capacity of rh3 in the DE (Figures 8B and 8C) . At low levels of Ss activity or with complete ablation, the general activators Sal and Otd induce expression of Rh3 in all R7s, including those in the ventral half (VE and VT) (Figures 8D-8F ). These observations support the requirement for the modulation of Ss levels to ensure proper regional Rh3 regulation. The presence of multiple K 50 (repressing via Dve and activating via Otd) and IroC (activating) binding sites in the rh3 promoter is consistent with the nature of this regulatory mechanism.
In contrast, the control of Rh4 appears to be much simpler: Ss/ Tgo, even at low levels, induces Rh4 expression ( Figure 8B ), likely by directly binding the lone canonical XRE (Ss/Tgo binding site) in the rh4 promoter. Perturbations of Ss/Tgo that yield derepression of Rh3, do not affect Rh4 expression (Figures 8C and  8D) . A subtle decrease in the frequency of Rh4 expression occurs in the DT where Ss levels are reduced only when Ss/Tgo activity is strongly impaired, likely because Ss/Tgo activity levels are near the threshold for activation ( Figure 8E ). Therefore, rh4 is highly responsive to Ss ensuring that it is expressed in yR7s in the DT where Ss levels are low. As Ss/Tgo activity decreases (C-F) or IroC activity increases (I), Rh3 expression expands in yR7s. As Ss/Tgo activity increases (A) or IroC activity decreases (G), Rh3 expression is lost in yR7s. Despite changes in Ss/Tgo or IroC activity, the frequency of Rh4 expression is robust (A-D, G-I) with only subtle changes observed in the DT where Ss levels are low in strong ss lof (E). Green indicates Ss/Tgo activity levels; magenta indicates IroC activity levels; blue indicates Rh3 expression frequency in yR7s; and Red indicates Rh4 expression frequency in yR7s. lof, loss-of-function; DT, dorsal third; DE, dorsal equatorial; VE, ventral equatorial; VT, ventral third. Ss expression is controlled by two main inputs: stochastic on/ off regulation and regional modulation of levels. The random, binary input determines pR7 (Ss Off) versus yR7 (Ss On) fate whereas the regional input determines main region (Ss high) versus DT (Ss low) yR7 fate. Although IroC is considered the critical factor determining dorsal identity in the retina, it does not appear to control regional modulation of Ss levels. Rather, another mechanism must work in parallel with IroC to control aspects of dorsal identity.
Despite dramatic changes in the activity of Ss and Tgo, Rh4 remains expressed in $65% of R7s. If the mechanism controlling stochastic subtype specification was dependent on Ss levels (e.g., via a feedback mechanism), a decrease in Ss/Tgo activity levels should cause a decrease in the frequency of Rh4-expressing yR7s with a concomitant increase in the number of Rh3-expressing pR7s. Here, we have shown that this is not the case: Ss levels do not play a role in determining the frequency of stochastic expression but rather are modulated to allow Rh3 expression in Rh4-expressing yR7s in the DT. Thus, the stochastic mechanism controlling Ss expression requires regulation of the ss promoter independent of feedback.
Proper Rhodopsin expression requires tight regulation of the levels of stochastically-expressed Ss. If Ss levels were highly variable, we would expect to see derepression of Rh3 in other R7s throughout the retina. Instead, we only observe expression of Rh3 in DT yR7s consistent with our findings that Ss levels are specifically lower there.
Our ongoing promoter dissection reveals that, not surprisingly, ss is controlled by a complex cis-regulatory logic (R.J.J., Jr. and C.D., unpublished data). It will be interesting to see how the ss gene integrates these two dramatically different types of inputs to produce its complex expression pattern.
EXPERIMENTAL PROCEDURES
Drosophila Strains and Crosses
Flies were raised on standard corn-meal-molasses-agar medium and grown at 25 C. In the Supplemental Experimental Procedures, we list all shortened genotypes, complete genotypes, figures in which they are examined, and original source for each reagent.
Antibodies
Antibodies and dilutions used were as follows: mouse anti-Rh3 (1:10) (gift from S. Britt, University of Colorado), rabbit anti-Rh4 (1:100) (gift from C. Zuker, Columbia University), mouse anti-Rh5 (1:200) (Chou et al., 1996) , rabbit antiRh6 (1:2,000) (Mikeladze-Dvali et al., 2005; Tahayato et al., 2003) , guinea pig anti-Ss 2.21 (1:200) (gift from Y.N. Jan, University of California, San Francisco) (Kim et al., 2006) , rabbit anti-Dve (1:500) (Nakagoshi et al., 1998) , mouse antiprospero (1:10) (DSHB), ms anti-Tgo (1:1, concentrated 10X) (DSHB), rat antiElaV (1:50) (DSHB), rabbit anti-Sens (1:100) (Xie et al., 2007) , rat anti-Sal (1:100) (Barrio et al., 1999) , guinea pig anti-Otd (1:750) (Vandendries et al., 1996) , sheep anti-GFP(1:500), and Alexa488 Phalloidin (1:80) (Invitrogen). All secondary antibodies were Alexa-conjugated (1:400) (Molecular Probes).
Antibody Staining: Pupal and Adult Retinas Adult or staged pupal retinas were dissected and fixed for 15 min with 4% formaldehyde at room temperature. Retinas were rinsed two times in PBS with 0.3% Triton X-100 (PBX) and washed in PBX for >2 hr. Retinas were incubated with primary antibodies diluted in PBX overnight at room temperature and then rinsed two times in PBX and washed in PBX for >4 hr. Retinas were incubated with secondary antibodies diluted in PBX overnight at room temperature and then rinsed two times in PBX and washed in PBX for >2 hr.
Retinas were mounted in Slofade (adult retinas) or Vectashield (pupal retinas).
Images were acquired using an SP5 Leica confocal microscope (Hsiao et al., 2012; Rister et al., 2013) .
Antibody Staining: Embryos Embryos were collected, dechorionated, fixed, and devitellinated. Embryos were washed three times and then stored in methanol. For staining, methanol was removed and embryos were rinsed and washed in PBX. Embryos were incubated with primary antibodies overnight at 4 C and then rinsed two times in PBX and washed in PBX for >4 hr. Embryos were incubated with secondary antibodies diluted in PBX overnight at 4 C and then rinsed two times in PBX and washed in PBX for >4 hr. Embryos were mounted in Aquapolymount (Polysciences) and images were acquired using an SP5 Leica confocal microscope.
Initial Screening of UAS>Ss modified Lines with Water Immersion Microscopy
We used the panR7>Gal4 (expressed in all R7s) and lGMR>Gal4 (expressed in all PRs) drivers to induce UAS>Ss modified expression in the eye and examined rh4 prom >GFP expression. Flies were adhered to a Petri dish using nail polish and immersed in water. The retina was observed for GFP expression using a compound fluorescence microscope (403 lens) (Pichaud and Desplan, 2001 ). We tested a minimum of two independent lines and found consistent results among lines ( Figures S2A-S2D ). We selected a single line for each UAS>Ss modified transgene for further analysis.
Generating tgo Null Alleles
The P(wHy)tgo DG08708 transposable element in tgo was used to generate null mutant alleles (Huet et al., 2002 (Lee and Luo, 2001 ). Embryos were collected for a 2 hr period and aged for 3 hr at 25 C. Embryos were then heat-shocked at 39 C for 50 min, allowed to recover for 30 min at 25 C, then heat-shocked again at 39 C for 45 min. Animals were reared at 18 C until the wandering larval stage, when GFP-positive clones were imaged. Morphology was analyzed in larval fillet preparations (Ye et al., 2004) immunostained with 1:350 Alexa Fluor 488 rabbit anti-GFP (Invitrogen), mounted in 70% glycerol, and imaged on a Leica SP5 confocal microscope using a 403/1.25 NA oil objective. The total number of terminal branches was quantified in projections of individual ddaC neurons from the second through fifth abdominal segment as previously described (Lee et al., 2003) .
In Figure S1L , all error bars are ±1 SD around the mean.
Transgenes tgo prom >GFP The tgo promoter was PCR amplified from wild-type flies (tgopromprimer1: 5 0 -CTGCAGCATGTGCATGTGCTACGACTG-3 0 and tgopromprimer2: 5 0 -GGA TCCGCTTGGAATGCGTAATTAGAAAACG-3 0 ) and cloned into the P-GEMT Easy vector. The tgo promoter was subcloned into an attB vector containing nuclearGFP using PstI and BamHI. Constructs were inserted into the J36 attP site (gift of K. Basler) on the third chromosome using phi-C31-mediated transgenesis (Bischof et al., 2007) . UAS>ss modified Fragments of ss were amplified from ss cDNA (Duncan et al., 1998) The rh3 promoter and the mutated rh3 promoters were subcloned into an attB vector containing GFP and miniwhite as selectable marker using BglII and NotI. Constructs were inserted into the J36 attP site on the third chromosome using phi-C31-mediated transgenesis (Bischof et al., 2007) . rh4 prom 
>GFP and Point Mutation
The rh4 promoter was PCR amplified from transgenic flies (rh4promprimer1: 5 0 -CTTTGGAGTACGAAATGCGTC-3 0 and rh4promprimer2: 5 0 -GTCCAGCTC GACCAGGATGGG-3 0 ) and cloned into the P-GEMT Easy vector. The rh4 promoter was subcloned into PBS using BamHI and EcoRI. rh4mutprimerFor (5 0 -CAATTAGACTTTGTGGTTGCTTGCCCGCAAAGACGATTTTC-3 0 ) and rh4 mutprimerRev (5 0 -GAAAATCGTCTTTGCGGGCAAGCAACCACAAAGTCTAA TTG-3 0 ) were used to induce the point mutation. The rh4 promoter and the rh4 promoter (point mutation) were subcloned into an attB vector containing GFP using BamHI and EcoRI. Constructs were inserted into the J36 attP site on the third chromosome using phi-C31-mediated transgenesis (Bischof et al., 2007) .
Quantification of Expression
Using cell-specific markers, antibody staining frequency was assessed for five or more retinas. Greater than 25 cells were scored per retina/region. We used the LAS-AF software to quantify Ss levels in wild-type animals (Figures 3A-3H ), Ss levels in yR7s (''On cells'') in wild-type and IroC mutant clones ( Figures 3I and 3J ), Dve levels in tgo 5 mutants ( Figures 6A and 6B ), GFP levels in wild-type DT and VT ( Figures 7E and 7F) , and GFP levels in wild-type and tgo 5 mutant clones ( Figures 7G and 7H) . A 1.3 um in diameter circular ''region of interest'' was manually placed at the center of each R7 to avoid signal from neighboring PRs. LAS-AF software assessed the Pixel intensity for each region of interest for each R7. All error bars in figures are ±1 SD around the mean.
Identification of Molecular Lesion in ss and tgo Alleles ss d116.4
We PCR amplified and sequenced the coding regions of the ss gene. We identified a deletion causing missense mutations and early termination ( Figure 5A ). tgo 6 We PCR amplified and sequenced the coding regions of the tgo gene. We identified a missense mutation causing early termination ( Figure 2B ).
Dp(3;2)P10
We used next-gen whole genome DNA sequencing to identify the breakpoint of this duplication in the ss locus (3R: 12,201,754). T(1;3)ss
